WOOJUNG BIO Inc (215380) - Total Liabilities

Latest as of June 2026: ₩76.72 Billion KRW ≈ $51.99 Million USD

Based on the latest financial reports, WOOJUNG BIO Inc (215380) has total liabilities worth ₩76.72 Billion KRW (≈ $51.99 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 215380 long-term investment intensity to see how much of total assets are deployed in long-term investments.

WOOJUNG BIO Inc - Total Liabilities Trend (2016–2025)

This chart illustrates how WOOJUNG BIO Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 215380 total assets.

WOOJUNG BIO Inc Competitors by Total Liabilities

The table below lists competitors of WOOJUNG BIO Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Spackman Equit V:SQG	Canada	CA$5.96 Million
PermRock Royalty Trust NYSE:PRT	USA	$378.83K
Kabelindo Murni Tbk JK:KBLM	Indonesia	Rp518.46 Billion
ARENA.PL S.A. ZY -50 F:8G6	Germany	€609.11K
FBR Ltd AU:FBR	Australia	AU$11.11 Million
West High Yield Resources Ltd V:WHY	Canada	CA$8.89 Million
Okong Corporation KQ:045060	Korea	₩25.00 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down WOOJUNG BIO Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See WOOJUNG BIO Inc (215380) balance sheet quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.55	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.89	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.74	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how WOOJUNG BIO Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for WOOJUNG BIO Inc (2016–2025)

The table below shows the annual total liabilities of WOOJUNG BIO Inc from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩63.42 Billion ≈ $42.98 Million	-2.92%
2024-12-31	₩65.33 Billion ≈ $44.27 Million	-14.45%
2023-12-31	₩76.36 Billion ≈ $51.75 Million	+16.98%
2022-12-31	₩65.28 Billion ≈ $44.24 Million	-4.95%
2021-12-31	₩68.68 Billion ≈ $46.54 Million	+64.36%
2020-12-31	₩41.78 Billion ≈ $28.32 Million	+34.91%
2019-12-31	₩30.97 Billion ≈ $20.99 Million	+31.15%
2018-12-31	₩23.61 Billion ≈ $16.00 Million	+80.62%
2017-12-31	₩13.07 Billion ≈ $8.86 Million	+812.36%
2016-12-31	₩1.43 Billion ≈ $971.15K	--

About WOOJUNG BIO Inc

KQ:215380 Korea Biotechnology

Market Cap

$24.40 Million

₩36.01 Billion KRW

Market Cap Rank

#24556 Global

#1757 in Korea

Share Price

₩2160.00

Change (1 day)

+1.89%

52-Week Range

₩1629.00 - ₩3605.00

All Time High

₩13450.00